Atossa Therapeutics
ATOS
#10714
Rank
NZ$42.43 M
Marketcap
NZ$4.25
Share price
-1.21%
Change (1 day)
209.52%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): NZ-$6.79

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$6.87. In 2025 the company made an earnings per share (EPS) of NZ-$7.01 a decrease over its 2024 EPS that were of NZ-$5.28.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.79-3.21%
2025NZ-$7.0132.89%
2024NZ-$5.28-15.56%
2023NZ-$6.2514.29%
2022NZ-$5.4716.67%
2021NZ-$4.69-90.86%
2020NZ-$51.28-2.96%
2019NZ-$52.85-63.09%
2018NZ-$143.18-49.63%
2017NZ-$284.28-57.87%
2016NZ-$674.77-74.01%
2015NZ-$2,596-9.18%
2014NZ-$2,858-12.86%
2013NZ-$3,28070.73%
2012NZ-$1,92134.07%
2011NZ-$1,433263.41%
2010NZ-$394.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.16-320.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.91-331.57%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.72-386.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.34-80.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-94.70%๐Ÿ‡บ๐Ÿ‡ธ USA